Artelo Biosciences, Inc.

NasdaqCM:ARTL Rapport sur les actions

Capitalisation boursière : US$3.7m

Artelo Biosciences Gestion

Gestion contrôle des critères 2/4

Artelo Biosciences' CEO is Greg Gorgas, appointed in Apr 2017, has a tenure of 7.58 years. total yearly compensation is $994.10K, comprised of 48.8% salary and 51.2% bonuses, including company stock and options. directly owns 0.63% of the company’s shares, worth $23.51K. The average tenure of the management team and the board of directors is 6 years and 6 years respectively.

Informations clés

Greg Gorgas

Directeur général

US$994.1k

Rémunération totale

Pourcentage du salaire du PDG48.8%
Durée du mandat du directeur général7.6yrs
Propriété du PDG0.6%
Durée moyenne d'occupation des postes de direction6yrs
Durée moyenne du mandat des membres du conseil d'administration6yrs

Mises à jour récentes de la gestion

Recent updates

Artelo jumps 21% as publication highlights pre-clinical data on drug platform

Aug 16

Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans

Mar 28
Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans

Artelo Biosciences Rounding A Corner With Cannabinoid-Based Therapy

Mar 09

Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?

Nov 02
Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?

Relief For Cancer Patients In Artelo Bioscience Pipeline

Jul 12

Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans

May 20
Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans

Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?

Feb 04
Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?

INO, VXRT, BTU and TTM among premarket gainers

Feb 02

Artelo Biosciences EPS misses by $0.04

Jan 14

Artelo Biosciences on go with cancer appetite recovery study

Nov 16

Analyse de la rémunération des PDG

Comment la rémunération de Greg Gorgas a-t-elle évolué par rapport aux bénéfices de Artelo Biosciences?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

-US$10m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$994kUS$485k

-US$9m

Sep 30 2023n/an/a

-US$10m

Jun 30 2023n/an/a

-US$9m

Mar 31 2023n/an/a

-US$10m

Dec 31 2022US$655kUS$440k

-US$10m

Sep 30 2022n/an/a

-US$13m

Jun 30 2022n/an/a

-US$13m

Mar 31 2022n/an/a

-US$12m

Dec 31 2021US$1mUS$142k

-US$12m

Nov 30 2021n/an/a

-US$9m

Aug 31 2021n/an/a

-US$7m

May 31 2021n/an/a

-US$7m

Feb 28 2021n/an/a

-US$5m

Nov 30 2020n/an/a

-US$5m

Aug 31 2020US$581kUS$431k

-US$5m

May 31 2020n/an/a

-US$4m

Feb 29 2020n/an/a

-US$4m

Nov 30 2019n/an/a

-US$3m

Aug 31 2019US$347kUS$209k

-US$2m

May 31 2019n/an/a

-US$2m

Feb 28 2019n/an/a

-US$2m

Nov 30 2018n/an/a

-US$3m

Aug 31 2018US$75kUS$75k

-US$2m

Rémunération vs marché: Greg's total compensation ($USD994.10K) is above average for companies of similar size in the US market ($USD655.65K).

Rémunération et revenus: Greg's compensation has increased whilst the company is unprofitable.


PDG

Greg Gorgas (61 yo)

7.6yrs

Titularisation

US$994,095

Compensation

Mr. Gregory D. Gorgas, also known as Greg, M.B.A. has been the Chief Executive Officer, President, Chief Financial Officer, Secretary and Treasurer of Artelo Biosciences, Inc. since April 3, 2017. He has e...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Gregory Gorgas
President7.6yrsUS$994.10k0.63%
$ 23.5k
Andrew Yates
Senior VP & Chief Scientific Officer3.8yrspas de donnéespas de données
Steven Reich
Chief Medical Officer6.6yrspas de donnéespas de données
Jason Baybutt
Senior Vice President of Finance5.5yrspas de donnéespas de données

6.0yrs

Durée moyenne de l'emploi

61yo

Âge moyen

Gestion expérimentée: ARTL's management team is seasoned and experienced (6 years average tenure).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Gregory Gorgas
President7.6yrsUS$994.10k0.63%
$ 23.5k
Connie Matsui
Independent Chairperson of the Board7.5yrsUS$74.41k0.12%
$ 4.3k
Robert Emanuele
Independent Director7.2yrsUS$41.91k0.026%
$ 959.1
Tamara Favorito
Independent Director3.7yrsUS$55.80kpas de données
Steven Kelly
Independent Director7.5yrsUS$57.41k0.026%
$ 959.1
Iwao Ojima
Member of the Advisory Board3.1yrspas de donnéespas de données
Gregory Reyes
Independent Director4yrsUS$42.41kpas de données
Richard Porter
Member of Scientific Advisory Board3.9yrspas de donnéespas de données
Douglas Blayney
Independent Director7.3yrsUS$45.91k0.026%
$ 959.1
Steven Laviolette
Member of Scientific Advisor Boardno datapas de donnéespas de données
Martin Kaczocha
Member of Scientific Advisory Board4.9yrspas de donnéespas de données

6.0yrs

Durée moyenne de l'emploi

69yo

Âge moyen

Conseil d'administration expérimenté: ARTL's board of directors are considered experienced (6 years average tenure).